Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Korean Drug Co. Ltd. (014570)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
3,505.
00
+35
+1.0086%
₩
35.29B
Market Cap
-
P/E Ratio
720%
Div Yield
4,389
Volume
-
Eps
₩
3,470
Previous Close
Watching
Watch
Add Transaction
Day Range
3,445
3,515
Year Range
3,060
4,700
Want to track
014570
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
Korean Drug Co. Ltd. (014570) Statistics
Valuation metrics
Market Cap
35.29B
Enterprise value
814.75M
Trailing P/E (ttm)
5.42
Forward P/E
-
PEG ratio
0.11
Price/Sales (ttm)
0.56
Price/Book (mrq)
0.43
Enterprise Value/Revenue
0.01
Enterprise Value/EBITDA
0.09
Overview
Shares outstanding
10.83M
Float
5.35M
Shares short
-
% Held by insiders
0.5%
% Held by institutions
-
Average volume (10 days)
28.61K
Average volume (90 days)
24.05K
Price summary
52-Week low
3,060
52-Week high
4,700
Beta
0.22
50-Day moving average
3,930.5
200-Day moving average
4,200.73
Dividends and splits
Forward annual dividend rate
720
Forward annual dividend yield
0.2209%
Trailing annual dividend rate
180
Trailing annual dividend yield
0.0552%
5-Year annual dividend yield
2.76%
Payout ratio
0.28
Dividend Date
5 Jan 2026
Ex-Dividend Date
29 Dec 2025
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.11%
Operating margin
0.09%
Operational effectiveness
Return on assets
0.05%
Return on equity
0.09%
Income Statement
Revenue (ttm)
62.76B
Revenue per share (ttm)
5,778.25
Quarterly revenue growth (yoy)
0.02%
Gross profit (ttm)
27.43B
EBITDA
10.38B
Net income to common (ttm)
6.91B
Diluted EPS (ttm)
602
Quarterly earnings growth (yoy)
0.5%
Balance Sheet
Total cash (mrq)
34.54B
Total cash per share (mrq)
3,192.38
Total debt (mrq)
83.07M
Total Debt/Equity (mrq)
0.1
Current ratio (mrq)
6.63%
Book value per share (mrq)
7,604.24
Cash Flow
Cash flow statement
11.1B
Levered free cash flow (LFCF)
9.41B